Related Articles
PD‑L1 expression levels on tumor cells affect their immunosuppressive activity
Antitumor effects of the silencing of programmed cell death ligand 1 in colorectal cancer via immunoregulation
EGF stimulates uPAR expression and cell invasiveness through ERK, AP-1, and NF-κB signaling in human gastric carcinoma cells
Combined inhibition of JAK1,2/Stat3‑PD‑L1 signaling pathway suppresses the immune escape of castration‑resistant prostate cancer to NK cells in hypoxia
Research progress on the intrinsic non‑immune function of PD‑L1 in tumors (Review)